232 related articles for article (PubMed ID: 31091126)
1. MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the
Salah SM; Meisenheimer JD; Rao R; Peda JD; Wallace DP; Foster D; Li X; Li X; Zhou X; Vallejo JA; Wacker MJ; Fields TA; Swenson-Fields KI
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F343-F360. PubMed ID: 31091126
[TBL] [Abstract][Full Text] [Related]
2. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
3. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic and fibrotic human PKD hearts are associated with macrophage infiltration and abnormal TGF-β
Amirrad F; Fishbein GA; Edwards RA; Nauli SM
Cell Tissue Res; 2023 Jan; 391(1):189-203. PubMed ID: 36376769
[TBL] [Abstract][Full Text] [Related]
6. Macrophages promote polycystic kidney disease progression.
Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
[TBL] [Abstract][Full Text] [Related]
7. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).
Belibi F; Zafar I; Ravichandran K; Segvic AB; Jani A; Ljubanovic DG; Edelstein CL
Am J Physiol Renal Physiol; 2011 May; 300(5):F1235-43. PubMed ID: 21270095
[TBL] [Abstract][Full Text] [Related]
10. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
11. Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion.
Chen HH; Lai PF; Lan YF; Cheng CF; Zhong WB; Lin YF; Chen TW; Lin H
J Cell Physiol; 2014 Sep; 229(9):1202-11. PubMed ID: 24420912
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.
Muchatuta MN; Gattone VH; Witzmann FA; Blazer-Yost BL
Exp Biol Med (Maywood); 2009 Jan; 234(1):17-27. PubMed ID: 18997107
[TBL] [Abstract][Full Text] [Related]
13. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
Tesch GH; Schwarting A; Kinoshita K; Lan HY; Rollins BJ; Kelley VR
J Clin Invest; 1999 Jan; 103(1):73-80. PubMed ID: 9884336
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.
Trial J; Heredia CP; Taffet GE; Entman ML; Cieslik KA
Basic Res Cardiol; 2017 Jul; 112(4):34. PubMed ID: 28478479
[TBL] [Abstract][Full Text] [Related]
17. Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Zoja C; Corna D; Locatelli M; Rottoli D; Pezzotta A; Morigi M; Zanchi C; Buelli S; Guglielmotti A; Perico N; Remuzzi A; Remuzzi G
Nephron; 2015; 129(1):52-61. PubMed ID: 25531096
[TBL] [Abstract][Full Text] [Related]
18. Renal remodelling in dietary protein modified rat polycystic kidney disease.
Bankovic-Calic N; Eddy A; Sareen S; Ogborn MR
Pediatr Nephrol; 1999 Sep; 13(7):567-70. PubMed ID: 10460502
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Chow FY; Nikolic-Paterson DJ; Ma FY; Ozols E; Rollins BJ; Tesch GH
Diabetologia; 2007 Feb; 50(2):471-80. PubMed ID: 17160673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
